# Flotek Industries Inc: overview FTK · NYSE · CIK 928054 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ftk.md) · [Financials](/companies/ftk/financials.md) · [Filings](/companies/ftk/filings.md) · [Insiders](/companies/ftk/insiders.md) Latest reported revenue: [$99.4m](/filings/0000928054-26-000080.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000928054-26-000080). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [49.7](/filings/0000928054-25-000098.md) | [50.8 d](/filings/0000928054-26-000020.md) | [55.4](/filings/0000928054-26-000047.md) | [58.4](/filings/0000928054-26-000080.md) | [56.0](/filings/0000928054-25-000098.md) | [67.5 d](/filings/0000928054-26-000020.md) | [70.1](/filings/0000928054-26-000047.md) | [99.4](/filings/0000928054-26-000080.md) | | Gross margin | % | [18.3%](/filings/0000928054-25-000098.md) | [24.2% d](/filings/0000928054-26-000020.md) | [22.5%](/filings/0000928054-26-000047.md) | [24.7%](/filings/0000928054-26-000080.md) | [31.7%](/filings/0000928054-25-000098.md) | [22.5% d](/filings/0000928054-26-000020.md) | [22.2%](/filings/0000928054-26-000047.md) | [23.9%](/filings/0000928054-26-000080.md) | | Operating margin | % | [5.5%](/filings/0000928054-25-000098.md) | [10.1% d](/filings/0000928054-26-000020.md) | [10.1%](/filings/0000928054-26-000047.md) | [4.4%](/filings/0000928054-26-000080.md) | [16.2%](/filings/0000928054-25-000098.md) | [8.9% d](/filings/0000928054-26-000020.md) | [10.8%](/filings/0000928054-26-000047.md) | [15.0%](/filings/0000928054-26-000080.md) | | Net margin | % | [5.1%](/filings/0000928054-25-000098.md) | [8.7% d](/filings/0000928054-26-000020.md) | [9.7%](/filings/0000928054-26-000047.md) | [3.0%](/filings/0000928054-26-000080.md) | [36.3%](/filings/0000928054-25-000098.md) | [4.5% d](/filings/0000928054-26-000020.md) | [6.7%](/filings/0000928054-26-000047.md) | [10.0%](/filings/0000928054-26-000080.md) | | Diluted EPS | $ per share | [0.08](/filings/0000928054-25-000098.md) | not reported | [0.17](/filings/0000928054-26-000047.md) | [0.05](/filings/0000928054-26-000080.md) | [0.53](/filings/0000928054-25-000098.md) | not reported | [0.12](/filings/0000928054-26-000047.md) | [0.26](/filings/0000928054-26-000080.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [39.6](/filings/0000928054-23-000052.md) | [136](/filings/0000928054-24-000023.md) | [188](/filings/0000928054-25-000017.md) | [187](/filings/0000928054-26-000020.md) | [237](/filings/0000928054-26-000020.md) | | Gross margin | % | [8.2%](/filings/0000928054-23-000052.md) | [(4.9%)](/filings/0000928054-24-000023.md) | [12.9%](/filings/0000928054-25-000017.md) | [21.1%](/filings/0000928054-26-000020.md) | [25.2%](/filings/0000928054-26-000020.md) | | Operating margin | % | [(79.4%)](/filings/0000928054-23-000052.md) | [(26.0%)](/filings/0000928054-24-000023.md) | [12.3%](/filings/0000928054-25-000017.md) | [6.5%](/filings/0000928054-26-000020.md) | [9.8%](/filings/0000928054-26-000020.md) | | Net margin | % | [(77.0%)](/filings/0000928054-23-000052.md) | [(31.1%)](/filings/0000928054-24-000023.md) | [13.1%](/filings/0000928054-25-000017.md) | [5.6%](/filings/0000928054-26-000020.md) | [12.9%](/filings/0000928054-26-000020.md) | | Diluted EPS | $ per share | [(0.42)](/filings/0000928054-23-000052.md) | [(3.41)](/filings/0000928054-24-000023.md) | [(0.10)](/filings/0000928054-25-000017.md) | [0.34](/filings/0000928054-26-000020.md) | [0.84](/filings/0000928054-26-000020.md) | | Free cash flow | $m | [(25.9)](/filings/0000928054-23-000052.md) | [(45.1)](/filings/0000928054-24-000023.md) | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ftk/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Driehaus Capital Management LLC](/funds/938206.md) | 2026-06-30 | $26.7m | 1,136,326 | | Added +167,669 | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $26.0m | 1,105,132 | | Added +267,007 | | [MASTERS CAPITAL MANAGEMENT LLC](/funds/1104186.md) | 2026-06-30 | $23.5m | 1,000,000 | | Reduced −89,438 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $20.2m | 856,775 | | Added +47,198 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $16.6m | 704,371 | | Added +12,778 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $15.0m | 639,794 | | Added +49,327 | | [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $14.4m | 612,926 | | Added +79,743 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $8.5m | 359,725 | | Added +32,966 | | [S SQUARED TECHNOLOGY, LLC](/funds/1322924.md) | 2026-06-30 | $7.3m | 309,807 | | Added +6,081 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $6.9m | 294,311 | | Reduced −1,240 | ## Recent filings [All 1,316 filings](/companies/ftk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-23 | 16:40 ET | [8-K](/filings/0000928054-26-000090.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000928054-26-000090 | | 2026-09-15 | 21:46 ET | [SCHEDULE 13D/A](/filings/0001104659-26-108028.md) | Ownership report, active investor, amended | 0001104659-26-108028 | | 2026-09-09 | 07:13 ET | [8-K](/filings/0000928054-26-000087.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000928054-26-000087 | | 2026-08-19 | 09:27 ET | [8-K](/filings/0000928054-26-000084.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000928054-26-000084 | | 2026-08-18 | 07:08 ET | [8-K](/filings/0000928054-26-000082.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000928054-26-000082 | | 2026-08-06 | 16:05 ET | [10-Q](/filings/0000928054-26-000080.md) | Quarterly report, period 2026-06-30 | 0000928054-26-000080 | | 2026-08-04 | 16:10 ET | [8-K](/filings/0000928054-26-000077.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000928054-26-000077 | | 2026-08-03 | 16:05 ET | [8-K](/filings/0000928054-26-000075.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000928054-26-000075 | | 2026-07-17 | 16:29 ET | [8-K](/filings/0000928054-26-000069.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000928054-26-000069 | | 2026-05-15 | 16:02 ET | [8-K](/filings/0000928054-26-000049.md) | 5.07 Shareholder vote results | 0000928054-26-000049 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000928054-26-000020.md), filed Mar 16, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/853e86e3-3977-4ec1-8159-f1efd38e0bc2) ## About the filer - CIK: 928054 - Tickers: FTK - Exchange: NYSE - SIC code: 2890 Miscellaneous Chemical Products - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.